V
48
4
TDC
46
-3
AVGO
45
3
MAC
46
2
RRC
43
-3
MU
56
-4
XRX
49
-3
AES
46
12
NKE
56
-2
CHD
40
3
GOOG
65
4
BBY
46
-10
CFG
97
-2
TROW
56
3
GME
44
4
STI
29
-5
BA
45
3
DD
64
3
AME
59
2
LB
14
-9
V
48
4
TDC
46
-3
AVGO
45
3
MAC
46
2
RRC
43
-3
MU
56
-4
XRX
49
-3
AES
46
12
NKE
56
-2
CHD
40
3
GOOG
65
4
BBY
46
-10
CFG
97
-2
TROW
56
3
GME
44
4
STI
29
-5
BA
45
3
DD
64
3
AME
59
2
LB
14
-9
Financhill
Back

Beam Therapeutics Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Buy
61

BEAM
Beam Therapeutics

Last Price:
$21.47
Seasonality Move:
-9.19%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 45.2% based on the past 5 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $21.46. The Score for BEAM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 45.2% based on the past 5 years of stock performance.

Beam Therapeutics Stock Rating

Buy
61
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
35.25
52-Week Low:
13.53

Prediction Charts

Market Cap:
2.2B
Price in USD:
21.46
Volume:
4M
Beta:
1.80

Technical Analysis

SMA50:
17.78
SMA100:
20.43
SMA200:
23.00
52-Wk Change:
-9.98%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 21.46 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-18 16.61 16.99 17.53 16.18
Jun-20 17.16 16.76 17.30 16.35
Jun-23 16.67 16.71 16.93 16.11
Jun-24 17.15 17.15 17.38 16.83
Jun-25 17.16 16.76 17.33 16.63
Jun-26 16.80 17.14 17.23 16.49
Jun-27 17.32 16.80 17.51 16.75
Jun-30 17.00 17.01 17.73 16.86
Jul-1 16.85 17.53 18.23 16.59
Jul-2 17.66 19.88 20.15 17.66
Jul-3 20.20 20.01 20.46 19.57
Jul-7 19.85 19.18 20.05 19.02
Jul-8 19.37 20.30 20.71 19.28
Jul-9 21.76 21.46 22.39 20.86

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.02 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.